AI assistance in minimally invasive pituitary surgery
Part of Brain & nervous system, Cancer, Hormones & metabolism clinical trials.
This early-stage trial tests artificial intelligence tools designed to help surgeons during a specific type of minimally invasive brain surgery (endoscopic transsphenoidal surgery) used to treat pituitary gland tumors or conditions. The AI may help surgeons navigate and identify key structures more precisely during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are scheduled for endoscopic transsphenoidal surgery (a minimally invasive procedure through the nose to reach the pituitary gland)
- You are able to understand the study and provide your own informed consent
- You are not having transcranial surgery (surgery that opens the skull) or microscopic transsphenoidal surgery (an older technique using a microscope instead of an endoscope)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new artificial intelligence tool that helps doctors plan your anesthesia before surgery. It is for adults who are having a planned non-heart surgery, and it aims to make the pre-anesthesia check smoother and more personalized.
This study tests whether a robot can help surgeons perform precise endoscopic procedures in the brain or pituitary area. It may be an option for people who need a ventriculostomy or surgery for a pituitary growth.
This trial tests an artificial-intelligence support tool that helps surgeons make decisions during surgery for rectal cancer. If you qualify, the tool may be used alongside the surgical team to support safer, more effective care.
This trial tests an AI tool that helps diagnose brain tumors like glioma, brain metastases, and lymphoma using MRI scans. It may allow faster and more accurate diagnosis without needing additional tests.
This trial is testing a computer system that helps doctors see blood vessels more clearly during a special type of endoscopy called third-space endoscopy. It aims to make the procedure safer for people with swallowing disorders or certain growths in the digestive tract.
This trial tests whether using artificial intelligence during a colonoscopy helps doctors find abnormal growths (polyps) in the colon more effectively than a standard colonoscopy alone. It may help detect problems early and prevent colon cancer.
Hear when a new Pituitary Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.